Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's Disease

NCT02728115 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Huntington Disease

Interventions

BIOLOGICAL: Cellavita HD Lower Dose
BIOLOGICAL: Cellavita HD Higher dose

Sponsor

Azidus Brasil

Collaborators

[object Object]
[object Object]